Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia Areata

NARecruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

December 15, 2023

Primary Completion Date

September 23, 2024

Study Completion Date

December 22, 2024

Conditions
Alopecia Areata
Interventions
DRUG

Lactic Acid

patients will be treated with MN combined with lactic acid solution 1%. Lactic acid solution 88% concentration PH (6.84), diluted with distilled water to have a final concentration of 1%

DRUG

vit D

patients will be treated with MN combined with topical application of vitamin D3 (an aqueous preparation of cholecalciferol (2.5 mg/ ml), The maximum total amount of vitamin D3 injected into a patient in every session will be 2.5 mg (1 ml)

DRUG

Triamcinolone Acetonide

patients will be treated with MN combined with triamcinolone acetonide injectable suspension (Epirelefan®, 40mg/ ml, Eipico, Egypt) (10 mg/ml) will be used in a dose of 0.1 ml/cm2 area

DRUG

Saline

patients will be treated with MN combined with normal saline 0.9%

Trial Locations (1)

44519

RECRUITING

Rana Ehab, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV